These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33876405)

  • 1. Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147.
    Ryan A; Patel P; O'Connor PM; Ross RP; Hill C; Hudson SP
    Drug Deliv Transl Res; 2021 Aug; 11(4):1735-1751. PubMed ID: 33876405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single versus double occupancy solid lipid nanoparticles for delivery of the dual-acting bacteriocin, lacticin 3147.
    Ryan A; Patel P; O'Connor PM; Cookman J; Ross RP; Hill C; Hudson SP
    Eur J Pharm Biopharm; 2022 Jul; 176():199-210. PubMed ID: 35640784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a solid lipid nanoparticle (SLN)-based lacticin 3147 hydrogel for the treatment of wound infections.
    Ryan A; Patel P; Ratrey P; O'Connor PM; O'Sullivan J; Ross RP; Hill C; Hudson SP
    Drug Deliv Transl Res; 2023 Sep; 13(9):2407-2423. PubMed ID: 36964439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract.
    Dobson A; Crispie F; Rea MC; O'Sullivan O; Casey PG; Lawlor PG; Cotter PD; Ross P; Gardiner GE; Hill C
    FEMS Microbiol Ecol; 2011 Jun; 76(3):602-14. PubMed ID: 21314706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multibacteriocin Cheese Starter System, Comprising Nisin and Lacticin 3147 in Lactococcus lactis, in Combination with Plantaricin from Lactobacillus plantarum.
    Mills S; Griffin C; O'Connor PM; Serrano LM; Meijer WC; Hill C; Ross RP
    Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28476774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous bacteriocin resistance in Listeria monocytogenes as a susceptibility screen for identifying different mechanisms of resistance and modes of action by bacteriocins of lactic acid bacteria.
    Macwana S; Muriana PM
    J Microbiol Methods; 2012 Jan; 88(1):7-13. PubMed ID: 22001443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q.
    Yoneyama F; Imura Y; Ohno K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3211-7. PubMed ID: 19470516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a lacticin 3147-enriched whey powder with inhibitory activity against foodborne pathogens.
    Morgan SM; Galvin M; Kelly J; Ross RP; Hill C
    J Food Prot; 1999 Sep; 62(9):1011-6. PubMed ID: 10492475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a spray-dried lacticin 3147 powder for the control of Listeria monocytogenes and Bacillus cereus in a range of food systems.
    Morgan SM; Galvin M; Ross RP; Hill C
    Lett Appl Microbiol; 2001 Nov; 33(5):387-91. PubMed ID: 11696102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential.
    McAuliffe O; Ryan MP; Ross RP; Hill C; Breeuwer P; Abee T
    Appl Environ Microbiol; 1998 Feb; 64(2):439-45. PubMed ID: 9464377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria.
    Fujita K; Ichimasa S; Zendo T; Koga S; Yoneyama F; Nakayama J; Sonomoto K
    Appl Environ Microbiol; 2007 May; 73(9):2871-7. PubMed ID: 17351096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.
    Rea MC; Clayton E; O'Connor PM; Shanahan F; Kiely B; Ross RP; Hill C
    J Med Microbiol; 2007 Jul; 56(Pt 7):940-946. PubMed ID: 17577060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of the two-component lantibiotic lacticin 3147 in the gastrointestinal tract.
    Gardiner GE; Rea MC; O'Riordan B; O'Connor P; Morgan SM; Lawlor PG; Lynch PB; Cronin M; Ross RP; Hill C
    Appl Environ Microbiol; 2007 Nov; 73(21):7103-9. PubMed ID: 17766459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Listeria monocytogenes in cottage cheese manufactured with a lacticin 3147-producing starter culture.
    McAuliffe O; Hill C; Ross RP
    J Appl Microbiol; 1999 Feb; 86(2):251-6. PubMed ID: 10063625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q.
    Li M; Yoneyama F; Toshimitsu N; Zendo T; Nakayama J; Sonomoto K
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3897-902. PubMed ID: 23733459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of live-culture-producing lacticin 3147 as a treatment for the control of Listeria monocytogenes on the surface of smear-ripened cheese.
    O'Sullivan L; O'connor EB; Ross RP; Hill C
    J Appl Microbiol; 2006; 100(1):135-43. PubMed ID: 16405693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-adapted Listeria monocytogenes displays enhanced tolerance against the lantibiotics nisin and lacticin 3147.
    van Schaik W; Gahan CG; Hill C
    J Food Prot; 1999 May; 62(5):536-9. PubMed ID: 10340677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14.
    Iwatani S; Zendo T; Yoneyama F; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2007 Aug; 71(8):1984-92. PubMed ID: 17690480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of sensitive and resistant Listeria monocytogenes strains against bacteriocins produced by different Enterococcus spp. strains.
    Ibarguren C; Guitián MV; Lenz RM; Cecilia SM; Audisio MC
    Int J Food Microbiol; 2022 Dec; 382():109928. PubMed ID: 36181756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.
    Masuda Y; Kawabata S; Uedoi T; Honjoh KI; Miyamoto T
    Microbiol Spectr; 2021 Sep; 9(1):e0014121. PubMed ID: 34259542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.